Sana Biotechnology, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
SANA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
188 East Blaine Street, Suite 400, Seattle, WA

There are no Buy or Sell transactions made by insiders since 10/4/2024

Sana Biotechnology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Flagship Ventures Fund V General Partner LLC 10%+ Owner $133M Jun 6, 2023
Flagship Pioneering Inc. 10%+ Owner $117M Feb 12, 2024
Keith Crandell 10%+ Owner $68.5M Feb 8, 2024
ARCH Venture Fund X, L.P. 10%+ Owner $68.5M Feb 8, 2024
Steve Harr President & CEO, Director $23.2M Mar 6, 2025
Hans Edgar Bishop Director $10.5M Jul 7, 2025
Richard Mulligan Director $10.5M Jun 5, 2025
Fmr Llc Other*, 10%+ Owner $7.49M Jan 8, 2025
Sunil Agarwal EVP, Head of Development & CMO $6.2M Mar 3, 2022
Christian Hordo EVP, Chief Business Officer $3.68M Mar 7, 2024
James J. MacDonald EVP & General Counsel $3.02M Jun 13, 2022
Susan D. Wyrick Acting Chief Financial Officer and Principal Accounting Officer $428K Mar 6, 2025
Bernard J. Cassidy EVP & General Counsel $374K Mar 6, 2025
Nathan Hardy EVP, Chief Financial Officer $369K Mar 7, 2024
Douglas E. Williams EVP & President, R&D $369K Mar 7, 2024
Flagship Pioneering Fund VII General Partner LLC 10%+ Owner Feb 12, 2024
Patrick Y. Yang Director Jun 5, 2025
Michelle Seitz Director Jun 5, 2025
Robert Nelsen Director, 10%+ Owner Jun 5, 2025
Douglas G. Cole Director Jun 6, 2024
Joshua H. Bilenker Director Jun 5, 2025
Robert L. Rosiello Director Jun 5, 2025
Mary Agnes Wilderotter Director Jun 5, 2025
Alise Reicin Director Jun 5, 2025

Recent Insider Transactions by Companies or Individuals for Sana Biotechnology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.